The Catalan test to predict the severity of breast cancer comes to Italy from the company that brought penicillin
Italian oncologists will be able to predict the severity of breast cancer at a very early stage thanks to Catalan technology. Inbiomotiona company that emerged as a result of research carried out at IRB Barcelona and ICREAhas reached an agreement with the Farmacéutica Italiana SPA Farma so that this company is the one that distributes … Read more